Shanghai Henlius Biotech, Inc. (HKG:2696)
Hong Kong
· Delayed Price · Currency is HKD 79.25
+2.35 (3.06%)
Aug 14, 2025, 3:45 PM HKT
Shanghai Henlius Biotech Market Cap
Shanghai Henlius Biotech has a market cap or net worth of 41.79 billion as of August 13, 2025. Its market cap has increased by 241.78% in one year.
Market Cap
41.79B
Enterprise Value
44.81B
Revenue
6.09B
Ranking
n/a
PE Ratio
47.87
Stock Price
79.25
Market Cap Chart
Since September 25, 2019, Shanghai Henlius Biotech's market cap has increased from 26.66B to 41.79B, an increase of 56.77%. That is a compound annual growth rate of 7.94%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 248.91B |
| Hansoh Pharmaceutical Group Company | 210.36B |
| JD Health International | 168.97B |
| Innovent Biologics | 156.29B |
| Akeso | 143.97B |
| Sino Biopharmaceutical | 131.63B |
| WuXi Biologics | 119.51B |
| CSPC Pharmaceutical Group | 117.30B |